The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in skin immune system;Rola metaloproteaz macierzy i tkankowych inhibitorów metaloproteaz w układzie odpornościowym skóry

Przeglad Dermatologiczny

Volumn 92, Issue 2, 2005, Pages 139-149

  Bogaczewicz, Jarosław ^a   Chodorowska, Grazyna ^a   Krasowska, Dorota ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Cytokines; Extracellular matrix; Matrix metalloproteinases; Skin immune system; Skin associated lymphoid tissue; Tissue inhibitors of metalloproteinases

Indexed keywords

COLLAGENASE 3; CYTOKINE; GELATINASE A; GELATINASE B; GROWTH FACTOR; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 19; MATRIX METALLOPROTEINASE 25; NEUTROPHIL COLLAGENASE; STROMELYSIN; STROMELYSIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE; UNCLASSIFIED DRUG;

BASEMENT MEMBRANE; CAPILLARY; CELL INTERACTION; CELL MIGRATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GENE INDUCTION; GENE REPRESSION; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; LANGERHANS CELL; LYMPHOCYTE; LYMPHOID TISSUE; MACROPHAGE; MAST CELL; MONOCYTE; NEUTROPHIL; REVIEW; SKIN; STROMA; VASCULAR ENDOTHELIUM; VENULE;

EID: 18844399344     PISSN: 00332526     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Loo W.J., Burrows N.P.: Management of autoimmune skin disorders in the elderly. Drugs Aging 2004, 21, 767-777.
2. Bos J.D.: The skin as an organ of immunity. Clin Exp Immunol 1997, 107, 3-5.
3. Streilein J.W.: Skin-associated lymphoid tissues (SALT): origins and functions. J Invest Dermatol 1983, 80, 12-16.
4. Sasaki T., Fassler R., Hohenester E. i inni: Laminin: the crux of basement membrane assembly. J Cell Biol 2004, 164, 959-963.
5. Bogaczewicz J., Chodorowska G., Krasowska D.: Rola metaloproteaz macierzy i tkankowych inhibitorów metaloproteaz w twardzinie układowej. Przegl Dermatol 2003, 90, 373-381.
6. Imai K., Hiramatsu A., Fukushima D. i inni: Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem J 1997, 322, 809-814.
7. Yu Q., Stamenkovic I.: Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 2000, 14, 163-176.
8. Ito A., Mukaiyama A., Itoh Y. i inni: Degradation of interleukin 1beta by matrix metalloproteinases. J Biol Chem 1996, 271, 14657-14660.
9. Sato S., Hayakawa I., Hasegawa M. i inni: Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis. J Invest Dermatol 2003, 120, 542-547.
10. ter Steege J., Vianen M., van Bilsen J. i inni: Identification of self-epitopes recognized by T cells in rheumatoid arthritis demonstrates matrix metalloproteinases as a novel T cell target. J Rheumatol 2003, 30, 1147-1156.
11. van Bilsen J.H., Wagenaar-Hilbers J.P., Grosfeld-Stulemeijer M.C. i inni: Matrix metalloproteinases as targets for the immune system during experimental arthritis. J Immunol 2004, 172, 5063-5068.
12. Sedlacek R., Mauch S., Kolb B. i inni: Matrix metalloproteinase MMP-19 (RASI-1) is expressed on the surface of activated peripheral blood mononuclear cells and is detected as an autoantigen in rheumatoid arthritis. Immunobiology 1998, 198, 408-423.
13. Van den Steen P.E., Proost P., Brand D.D. i inni: Generation of glycosylated remnant epitopes from human collagen type II by gelatinase B. Biochemistry 2004, 43, 10809-10816.
14. Bogaczewicz J., Chodorowska G., Krasowska D.: Rola metaloproteaz macierzy i tkankowych inhibitorów metaloproteaz w gojeniu siȩ ran skóry. Przegl Dermatol 2004, 91, 253-261.
15. Bogaczewicz J., Krasowska D., Stryjecka-Zimmer M. i inni: Wysokie stéżenia tkankowego inhibitora metaloproteaz-1 (TIMP-1) w surowicy krwi chorych na twardzinȩ układowa̧zwia̧zek z obecnościa̧ zmian narza̧dowych. Przegl Dermatol 2004, 91, 467-474.
16. Bogaczewicz J., Chodorowska G., Krasowska D.: Rola metaloproteaz macierzy i tkankowych inhibitorów metaloproteaz w starzeniu siȩ słonecznym skóry. Przegl Dermatol 2004, 91, 163-168.
17. Heffler L.C., Kastman A.L., Jacobsson Ekman G. i inni: Langerhans cells that express matrix metalloproteinase 9 increase in human dermis during sensitization to diphenylcyclopropenone in patients with alopecia areata. Br J Dermatol 2002, 147, 222-229.
18. Ratzinger G., Stoitzner P., Ebner S. i inni: Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin. J Immunol 2002, 168, 4361-4371.
19. Katoh N., Hirano S., Suehiro M. i inni: Increased levels of serum tissue inhibitor of metalloproteinase-1 but not metalloproteinase-3 in atopic dermatitis. Clin Exp Immunol 2002, 127, 283-288.
20. Matache C., Stefanescu M., Dragomir C. i inni: Matrix metalloproteinase-9 and its natural inhibitor TIMP-1 expressed or secreted by peripheral blood mononuclear cells from patients with systemic lupus erythematosus. J Autoimmun 2003, 20, 323-331.
21. Suomela S., Kariniemi A.L., Snellman E. i inni: Metalloelastase (MMP-12) and 92-kDa gelatinase (MMP-9) as well as their inhibitors, TIMP-1 and -3, are expressed in psoriatic lesions. Exp Dermatol 2001, 10, 175-183.
22. Suomela S., Kariniemi A.L., Impola U. i inni: Matrix metalloproteinase-19 is expressed by keratinocytes in psoriasis. Acta Derm Venereol (Stockh) 2003, 83, 108-114.
23. Giannelli G., Brassard J., Foti C. i inni: Altered expression of basement membrane proteins and their integrin receptors in lichen planus: possible pathogenetic role of gelatinases A and B. Lab Invest 1996, 74, 1091-1104.
24. Liu Z., Zhou X., Shapiro S.D. i inni: The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell 2000, 102, 647-655.
25. Chromek M., Tullus K., Lundahl J. i inni: Tissue inhibitor of metalloproteinase 1 activates normal human granulocytes, protects them from apoptosis, and blocks their transmigration during inflammation. Infect Immun 2004, 72, 82-88.
26. Xie Z., Singh M., Singh K.: Differential regulation of matrix metalloproteinase-2 and -9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1beta. J Biol Chem 2004, 279, 39513-39519.
27. Everts V., van der Zee E., Creemers L. i inni: Phagocytosis and intracellular digestion of collagen, its role in turnover and remodelling. Histochem J 1996, 28, 229-245.
28. Leppert D., Waubant E., Galardy R. i inni: T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 1995, 154, 4379-4389.
29. Liu L., Kubes P.: Molecular mechanisms of leukocyte recruitment: organ-specific mechanisms of action. Thromb Haemost 2003, 89, 213-220.
30. Faveeuw C., Preece G., Ager A.: Transendothelial migration of lymphocytes across high endothelial venules into lymph nodes is affected by metalloproteinases. Blood 2001, 98, 688-695.
31. Leppert D., Waubant E., Burk M.R. i inni: Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis. Ann Neurol 1996, 40, 846-852.
32. Burger D., Rezzonico R., Li J.M. i inni: Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines. Arthritis Rheum 1998, 41, 1748-1759.
33. Zhang J.H., Ferrante A., Arrigo A.P. i inni: Neutrophil stimulation and priming by direct contact with activated human T lymphocytes. J Immunol 1992, 148, 177-181.
34. Lacraz S., Isler P., Vey E. i inni: Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression. J Biol Chem 1994, 269, 22027-22033.
35. Johnatty R.N., Taub D.D., Reeder S.P. i inni: Cytokine and chemokine regulation of pro-MMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J Immunol 1997, 158, 2327-2333.
36. Stuve O., Dooley N.P., Uhni J.H. i inni: Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol 1996, 40, 853-863.
37. Romanic A.M., Madri J.A.: The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent. J Cell Biol 1994, 125, 1165-1178.
38. Xia M., Sreedharan S.P., Dazin P. i inni: Integrin-dependent role of human T cell matrix metalloproteinase activity in chemotaxis through a model basement membrane. J Cell Biochem 1996, 61, 452-458.
39. Yakubenko V.P., Lobb R.R., Plow E.F. i inni: Differential induction of gelatinase B (MMP-9) and gelatinase A (MMP-2) in T lymphocytes upon alpha(4)beta(1)-mediated adhesion to VCAM-1 and the CS-1 peptide of fibronectin. Exp Cell Res 2000, 260, 73-84.
40. Feinberg M.W., Jain M.K., Werner F. i inni: Transforming growth factor-beta 1 inhibits cytokine-mediated induction of human metalloelastase in macrophages. J Biol Chem 2000, 275, 25766-25773.
41. Rajavashisth T.B., Xu X.P., Jovinge S. i inni: Membrane type 1 matrix metalloproteinases expression in human atherosclerotic plaques. Evidence for activation by proinflammatory mediators. Circulation 1999, 99, 3103-3109.
42. Saren P., Welgus H.G., Kovanen P.T.: TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 1996, 157, 4159-4165.
43. Busiek D.F., Baragi V., Nehring L.C. i inni: Matrilysin expression by human mononuclear phagocytes and its regulation by cytokines and hormones. J Immunol 1995, 154, 6484-6491.
44. Lacraz S., Nicod L.P., Chicheportiche R. i inni: IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 1995, 96, 2304-2310.
45. Kumar R., Dong Z., Fidler I.J.: Differential regulation of metalloelastase activity in murine peritoneal macrophages by granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor. J Immunol 1996, 157, 5104-5111.
46. Shapiro S.D., Kobayashi D.K., Pentland A.P. i inni: Induction of macrophage metalloproteinases by extracellular matrix. Evidence for enzyme- and substrate-specific responses involving prostaglandin-dependent mechanisms. J Biol Chem 1993, 268, 8170-8175.
47. Corcoran M.L., Kibbey M.C., Kleinman H.K. i inni: Laminin SIKVAV peptide induction of monocyte/macrophage prostaglandin E2 and matrix metalloproteinases. J Biol Chem 1995, 270, 10365-10368.
48. Amorino G.P., Hoover R.L.: Interactions of monocytic cells with human endothelial cells stimulate monocytic metalloproteinase production. Am J Pathol 1998, 152, 199-207.
49. Wu L., Fan J., Matsumoto S. i inni: Induction and regulation of matrix metalloproteinase-12 by cytokines and CD40 signaling in monocyte/macrophages. Biochem Biophys Res Commun 2000, 269, 808-815.
50. Herman M.P., Sukhova G.K., Libby P. i inni: Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling. Circulation 2001, 104, 1899-1904.
51. Miltenburg A.M., Lacraz S., Welgus H.G. i inni: Immobilized anti-CD3 antibody activates T cell clones to induce the production of interstitial collagenase, but not tissue inhibitor of metalloproteinases, in monocytic THP-1 cells and dermal fibroblasts. J Immunol 1995, 154, 2655-2667.
52. Matsuda A., Itoh Y., Koshikawa N. i inni: Clusterin, an abundant serum factor, is a possible negative regulator of MT6-MMP/MMP-25 produced by neutrophils. J Biol Chem 2003, 278, 36350-36357.
53. Hanemaaijer R., Koolwijk P., le Clercq L. i inni: Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. Biochem J 1993, 296, 803-809.
54. Hojo Y., Ikeda U., Takahashi M. i inni: Matrix metalloproteinase-1 expression by interaction between monocytes and vascular endothelial cells. J Mol Cell Cardiol 2000, 32, 1459-1468.
55. Baram D., Vaday G.G., Salamon P. i inni: Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-alpha. J Immunol 2001, 167, 4008-4016.
56. Bogaczewicz J., Chodorowska G., Krasowska D.: Rola metaloproteaz macierzy i tkankowych inhibitorów metaloproteaz w progresji noworworów skóry a nowe strategie farmakologicznej inhibicji metaloproteaz macierzy. Przegl Dermatol 2004, 91, 153-160.
57. Sheu B.C., Hsu S.M., Ho H.N. i inni: A novel role of metalloproteinase in cancer-mediated immunosuppression. Cancer Res 2001, 61, 237-542.
58. Noe V., Fingleton B., Jacobs K. i inni: Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 2001, 114, 111-118.
59. Preece G., Murphy G., Ager A.: Metalloproteinase-mediated regulation of L-selectin levels on leucocytes. J Biol Chem 1996, 271, 11634-11640.
60. Haro H., Crawford H.C., Fingleton B. i inni: Matrix metalloproteinase-7- dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. J Clin Invest 2000, 105, 143-150.
61. Powell W.C., Fingleton B., Wilson C.L. i inni: The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr Biol 1999, 9, 1441-1447.
62. English W.R., Puente X.S., Freije J.M. i inni: Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2. J Biol Chem 2000, 275, 14046-14055.
63. McQuibban G.A., Gong J.H., Tarn E.M. i inni: Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 2000, 289, 1202-1206.
64. Levi E., Fridman R., Miao H.Q. i inni: Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proc Natl Acad Sci U S A 1996, 93, 7069-7074.
65. Sadowski T., Dietrich S., Koschinsky F. i inni: Matrix metalloproteinase 19 regulates insulin-like growth factor-mediated proliferation, migration, and adhesion in human keratinocytes through proteolysis of insulin-like growth factor binding protein-3. Mol Biol Cell 2003, 14, 4569-4580.
66. White J.M.: ADAMs: modulators of cell-cell and cell-matrix interactions. Curr Opin Cell Biol 2003, 15, 598-606.
67. Amour A., Slocombe P.M., Webster A. i inni: TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 1998, 435, 39-44.